KALIF ELIYAHU SHARON (EVP, Chief Financial Officer) sold 12.1% of their position (55.77K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $952.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2025ACC: 0000950170-25-086697
Officer· EVP, Chief Financial Officer
Since Dec 2019
-55.77K
Net shares
Net seller
$952.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
55.77K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−55.77K
Price / share
$17.08
Trade value
$952.46K
% of position
12.1%
6/12/2025
459.06K→403.29K
Total
Net shares
−55.77K
Net value
-$952.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/12/2025 | S · Sale | −55.77K | $17.08 | $952.46K | 12.1% | 459.06K | 403.29K |
| Total | −55.77K | -$952.46K | ||||||
Derivative Transactions0
No derivative transactions reported